{"id":36062,"date":"2026-06-02T12:50:33","date_gmt":"2026-06-02T16:50:33","guid":{"rendered":"https:\/\/geiselmed.dartmouth.edu\/news\/?p=36062"},"modified":"2026-06-02T12:50:33","modified_gmt":"2026-06-02T16:50:33","slug":"landmark-cancer-trial-shows-success-against-undruggable-cancer-raising-hopes-for-future-treatments-nature","status":"publish","type":"post","link":"https:\/\/geiselmed.dartmouth.edu\/news\/2026\/landmark-cancer-trial-shows-success-against-undruggable-cancer-raising-hopes-for-future-treatments-nature\/","title":{"rendered":"Landmark Cancer Trial Shows Success Against &#8216;Undruggable&#8217; Cancer \u2014 Raising Hopes for Future Treatments\u2014<em>Nature<\/em>"},"content":{"rendered":"<p><a href=\"https:\/\/dartmouth.us1.list-manage.com\/track\/click?u=e2de137c4974374fa3c312663&amp;id=4100189a1f&amp;e=abffd9bbab\" target=\"_blank\" rel=\"noopener\"><em>Read article<\/em><\/a>\u2014Features Michael Cole, a professor of molecular and systems biology, in an article on new approaches to targeting MYC, a cancer-driving protein long considered \"undruggable.\" The article reports that Cole is investigating compounds that could block MYC's ability to activate genes involved in tumor growth following a breakthrough pancreatic cancer trial targeting RAS proteins.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"https:\/\/dartmouth.us1.list-manage.com\/track\/click?u=e2de137c4974374fa3c312663&amp;id=4100189a1f&amp;e=abffd9bbab\" target=\"_blank\" rel=\"noopener\"><em>Read article<\/em><\/a>\u2014Features Michael Cole, a professor of molecular and systems biology, in an article on new approaches to targeting MYC, a cancer-driving protein long considered &#8220;undruggable.&#8221; The article reports that Cole is investigating compounds that could block MYC&#8217;s ability to activate genes involved in tumor growth following a breakthrough pancreatic cancer trial targeting RAS proteins.<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5],"tags":[],"class_list":["post-36062","post","type-post","status-publish","format-standard","hentry","category-in-the-news","author-15"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4r3h1-9nE","_links":{"self":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/36062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/comments?post=36062"}],"version-history":[{"count":1,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/36062\/revisions"}],"predecessor-version":[{"id":36063,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/36062\/revisions\/36063"}],"wp:attachment":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/media?parent=36062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/categories?post=36062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/tags?post=36062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}